Drugmaker Gilead Sciences sets remdesivir price at $2,340 per treatment
Monday, June 29, 2020 - 08:42
in Health & Medicine
U.S. drugmaker Gilead Sciences said Monday it will charge $2,340 per treatment for its experimental drug remdesivir, which has been shown to reduce the time needed for a patient to recover from COVID-19.